- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT05097755
The Time Delay Correlated With LV Functions and Heart Failure Incidence in STEMI?!
January 21, 2023 updated by: mustafa Zayan Abdelsayed Mohamed
In Non-diabetic Patients With STEMI Treated With Primary PCI: is the Time Delay Correlated With LV Functions and Heart Failure Incidence?!
To find out if the time delays between the first medical contacts till the device has an impact on LV functions estimated by transthoracic Echocardiography and if it's correlated to heart failure incidence in non-diabetic patients with STEMI treated with primary PCI
Study Overview
Status
Not yet recruiting
Conditions
Study Type
Observational
Enrollment (Anticipated)
345
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Contact
- Name: Mustafa Z. Abdelsayed
- Phone Number: +20 1067982167
- Email: mustafa.zaian54@gmail.com
Study Contact Backup
- Name: Hatem A. Helmy
- Phone Number: +20 100 521 2162
- Email: hatem19652007@yahoo.com
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
20 years to 80 years (Adult, Older Adult)
Accepts Healthy Volunteers
N/A
Genders Eligible for Study
All
Sampling Method
Non-Probability Sample
Study Population
- All patients will be subjected to:
Calculation of time from the first medical contact to time of primary PCI.
- Full history taking: including age, sex, history of HTN, Smoking, dyslipidemia, IHD
Description
Inclusion Criteria:
- Subjects with anterior STEMI according to ESC guidelines 2017.
- Subjects undergoing PPCI for the first time .
- Non diabetic patients.
Exclusion Criteria:
• Patients with previous PCI.
- Patients with previous CABG.
- Patients with TIMI flow II or less .
- Cardiogenic shock.
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Observational Models: Cohort
- Time Perspectives: Prospective
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
to what extent could the time be relevant to the incidence of Heart failure
Time Frame: baseline
|
is the time delay correlated with LV functions and heart failure incidence?!
|
baseline
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Anticipated)
March 1, 2023
Primary Completion (Anticipated)
June 1, 2024
Study Completion (Anticipated)
October 1, 2024
Study Registration Dates
First Submitted
October 17, 2021
First Submitted That Met QC Criteria
October 17, 2021
First Posted (Actual)
October 28, 2021
Study Record Updates
Last Update Posted (Estimate)
January 24, 2023
Last Update Submitted That Met QC Criteria
January 21, 2023
Last Verified
January 1, 2023
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- LV functions in STEMI
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.